Our analysis revealed that TACC3 expression significantly correlated with 88.1% (37/42) of the immune markers identified in KIRC, which validated the results of our previous analyses and further suggested that TACC3 plays a significant role in tumor immune infiltration (p < 0.05). The gene discussed is TACC3; the disease is neoplasm.